STERIS plc (STE)
STERIS plc is a healthcare equipment and services company focused on infection prevention. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment includes cleaning chemistries, sterility assurance products, endoscope reprocessing systems, tracking products, endoscopy accessories, washers, sterilizers, and other capital equipment used in sterile processing departments and procedure rooms. This segment also provides installation, maintenance, repair, upgrading, troubleshooting, and related consulting and outsourced sterile processing services. AST supplies contract sterilization and testing services, along with sterilization equipment and control systems, to medical device and pharmaceutical customers. The Life Sciences segment develops and sells consumable products and equipment used in pharmaceutical, cleanroom, and water purity applications. STERIS serves hospitals, healthcare providers, pharmaceutical manufacturers, and related institutions. Founded in 1985, the company is headquartered in Mentor, Ohio, and its common stock trades on the NYSE under the symbol STE.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-STE
|
$247.25
|
18.1% Upside
|
Undervalued
|
$263.13
|
25.7% Upside
|
Undervalued
|
Great
|
September 25, 2026
|
1.3%
|
November 11, 2026
|
25.4x
|
2.8x
|
3.4x
|
20.465 B
|
22.042 B
|
9.1%
|
99.6%
|
6.6
|
30.7%
|
115.0%
|
